117 related articles for article (PubMed ID: 23400833)
1. Does removal of out-of-pocket costs for cervical and breast cancer screening work? A quasi-experimental study to evaluate the impact on attendance, attendance inequality and average cost per uptake of a Japanese government intervention.
Tabuchi T; Hoshino T; Nakayama T; Ito Y; Ioka A; Miyashiro I; Tsukuma H
Int J Cancer; 2013 Aug; 133(4):972-83. PubMed ID: 23400833
[TBL] [Abstract][Full Text] [Related]
2. An Out-of-Pocket Cost Removal Intervention on Fecal Occult Blood Test Attendance.
Tabuchi T; Murayama H; Hoshino T; Nakayama T
Am J Prev Med; 2017 Aug; 53(2):e51-e62. PubMed ID: 28236518
[TBL] [Abstract][Full Text] [Related]
3. Predictors of breast and cervical cancer screening in a Spanish metropolitan area.
López-de-Andrés A; Martin-Lopez R; Hernández-Barrera V; Carrasco-Garrido P; Gil-de-Miguel A; Esteban y Peña MM; Jiménez-García R
J Womens Health (Larchmt); 2010 Sep; 19(9):1675-81. PubMed ID: 20799924
[TBL] [Abstract][Full Text] [Related]
4. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
[TBL] [Abstract][Full Text] [Related]
5. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
[TBL] [Abstract][Full Text] [Related]
6. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
[TBL] [Abstract][Full Text] [Related]
7. Improving uptake of cervical cancer screening in women with prolonged history of non-attendance for screening: a randomized trial of enhanced invitation methods.
Stein K; Lewendon G; Jenkins R; Davis C
J Med Screen; 2005; 12(4):185-9. PubMed ID: 16417695
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
[TBL] [Abstract][Full Text] [Related]
9. To what extent is women's economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010.
Menvielle G; Richard JB; Ringa V; Dray-Spira R; Beck F
Cancer Causes Control; 2014 Aug; 25(8):977-83. PubMed ID: 24842393
[TBL] [Abstract][Full Text] [Related]
10. Breast and cervical cancer screening in Spain and predictors of adherence.
Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
[TBL] [Abstract][Full Text] [Related]
11. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.
Holmes J; Hemmett L; Garfield S
Eur J Health Econ; 2005 Mar; 6(1):30-7. PubMed ID: 15682286
[TBL] [Abstract][Full Text] [Related]
14. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
15. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
16. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
17. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
18. [The cost of screening for breast and cervical cancer in France].
Watt S
Bull Cancer; 2003 Nov; 90(11):997-1004. PubMed ID: 14706904
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region.
Oussaid N; Lutringer-Magnin D; Barone G; Haesebaert J; Lasset C
Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357
[TBL] [Abstract][Full Text] [Related]
20. Promotion of cervical screening among nonattendees: a partial cost-effectiveness analysis.
Oscarsson MG; Benzein EG; Wijma BE; Carlsson PG
Eur J Cancer Prev; 2007 Dec; 16(6):559-63. PubMed ID: 18090130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
